Romatoid Artrit’in Histopatolojik Etkileri, Tanı ve Tedavi Yöntemleri
Özet
Romatoid artrit (RA), başta eklemler olmak üzere kalp, akciğer ve böbrek gibi eklem dışı organları da etkileyebilen kronik, sistemik ve otoimmün bir inflamatuvar hastalıktır. Dünya genelinde prevelansı %1-1,5 civarında olan hastalık, tipik olarak 30-50 yaş aralığında ve kadınlarda 2 ila 4 kat daha sık görülür. Genetik (HLA-DR4/HLA-DRB1) ve sigara gibi çevresel faktörlerin etkileşimiyle gelişen hastalıkta, proteinlerin sitrülinasyonu ve anti-sitrülinlenmiş protein antikorlarının (ACPA) oluşumu temel immünolojik süreçleri oluşturur. Histopatolojik olarak sinoviyal membranda hiperplazi, anjiyogenez, pannus oluşumu ve inflamatuvar hücre infiltrasyonu gözlenir; salınan matriks metalloproteinazlar (MMP) ve osteoklast aktivasyonu eklem kıkırdağı ile kemik yıkımına yol açar. Klinik olarak simetrik çoklu eklem ağrısı, şişlik ve sabah tutukluğu ile karakterize olan RA; kardiyovasküler, solunum ve nörolojik sistem komorbiditeleri nedeniyle mortalite oranını artırır. Tanı aşamasında klinik bulguların yanı sıra RF, anti-CCP, ESH ve CRP testleri ile radyolojik Sharp skoru değerlendirmelerinden yararlanılır. Kesin bir tedavisi bulunmayan RA’in yönetiminde, EULAR hedefe yönelik tedavi yaklaşımı doğrultusunda semptomları hafifletmek ve eklem hasarını onarmak amacıyla konvansiyonel sentetik DMARD'lar (metotreksat), kortikosteroidler, biyolojik ajanlar (TNF ve IL-6 inhibitörleri) ve JAK inhibitörleri bireysel olarak uygulanmaktadır.
Rheumatoid arthritis (RA) is a chronic, systemic, and autoimmune inflammatory disease that primarily targets the joints but can also damage extra-articular organs such as the heart, lungs, and kidneys. With a global prevalence of approximately 1-1.5%, it typically manifests in individuals aged 30-50 and occurs 2 to 4 times more frequently in women. Developed through the interplay of genetic predisposition (HLA-DR4/HLA-DRB1) and environmental factors like smoking, the disease features protein citrullination and the production of anti-citrullinated protein antibodies (ACPA) as core immunologic processes. Histopathologically, the synovial membrane exhibits hyperplasia, angiogenesis, pannus formation, and inflammatory cell infiltration, where released matrix metalloproteinases (MMPs) and osteoclast activation cause joint cartilage and bone destruction. Clinically characterized by symmetrical multi-joint pain, swelling, and morning stiffness, RA increases mortality rates due to cardiovascular, respiratory, and neurological comorbidities. Diagnosis relies on clinical symptoms alongside RF, anti-CCP, ESR, and CRP tests, combined with radiological Sharp score evaluations. Lacking a definitive cure, RA management utilizes personalized regimens including conventional synthetic DMARDs (methotrexate), corticosteroids, biological agents (TNF and IL-6 inhibitors), and JAK inhibitors under the EULAR treat-to-target strategy to alleviate symptoms and prevent joint damage progression.
Referanslar
Khurana R, Berney SM. Clinical aspects of rheumatoid arthritis. Pathophysiology. 2005;12(3):153-165.
Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. The American Journal of Medicine. 2007;120(11):936-939.
Tanaka Y. Rheumatoid arthritis. Inflammation and Regeneration. 2020;40:20.
Cutolo M, Giusti M, Foppiani L, et al. The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. Zeitschrift für Rheumatologie. 2000;59.
Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis & Rheumatology. 2004;50(2):380-386.
Rantapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatology. 2003;48(10):2741-2749.
van de Sande MG, de Hair MJ, van der Leij C, et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Annals of Rheumatic Diseases. 2011;70(5):772-777.
Hurd ER. Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum. 1979;8(3):151-76.
Gregersen PK. Genetics of rheumatoid arthritis: confronting complexity. Arthritis Research & Therapy. 1999;1(1):37-44.
Rigby AS, Silman AJ, Voelm L, et al. Investigating the HLA component in rheumatoid arthritis: an additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genetic Epidemiology. 1991;8(3):153-175.
McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389(10086):2328-2337.
Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nature Reviews Disease Primers. 2018;4:18001.
Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Annals of Rheumatic Diseases. 2010;69(1):70-81.
Alsaber A, Pan J, Al-Herz A, et al. Influence of Ambient Air Pollution on Rheumatoid Arthritis Disease Activity Score Index. International Journal of Environmental Research and Public Health. 2020;17(2).
Tedeschi SK, Costenbader KH. Is There a Role for Diet in the Therapy of Rheumatoid Arthritis? Current Rheumatology Reports. 2016;18(5):23.
Pattison DJ, Symmons DP, Young A. Does diet have a role in the aetiology of rheumatoid arthritis? Proceedings of the Nutrition Society. 2004;63(1):137-143.
Armstrong DJ, McCausland EM, Quinn AD, et al. Obesity and cardiovascular risk factors in rheumatoid arthritis. Rheumatology (Oxford). 2006;45(6):782-783.
Maxwell JR, Gowers IR, Moore DJ, et al. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology (Oxford). 2010;49(11):2140-2146.
Fakra E, Marotte H. Rheumatoid arthritis and depression. Joint Bone Spine. 2021;88(5):105200.
Kouri T, Petersen J, Rhodes G, et al. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. The Journal of Rheumatology. 1990;17(11):1442-1449.
Hajeer AH, MacGregor AJ, Rigby AS, et al. Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs. Annals of Rheumatic Diseases. 1994;53(2):137-139.
Walker DJ, Griffiths ID, Madeley D. Autoantibodies and antibodies to microorganisms in rheumatoid arthritis: comparison of histocompatible siblings. The Journal of Rheumatology. 1987;14(3):426-428.
Li M, Wang F. Role of Intestinal Microbiota on Gut Homeostasis and Rheumatoid Arthritis. Journal of Immunology Research. 2021;2021:8167283.
Song GG, Bae SC, Lee YH. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clinical Rheumatology. 2012;31(12):1733-1739.
Smith MD, Barg E, Weedon H, et al. Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. Annals of Rheumatic Diseases. 2003;62(4):303-7.
Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, et al. Pro- and anti-inflammatory cytokines increase hyaluronan production by rat synovial membrane in vitro. International Journal of Molecular Medicine. 2009;24(4):579-585.
Gao W, McCormick J, Connolly M, et al. Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis. Annals of Rheumatic Diseases. 2015;74(6):1275-1283.
Oliver KM, Garvey JF, Ng CT, et al. Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. Antioxidants & Redox Signaling. 2009;11(9):2057-2064.
Firestein GS, McInnes IB. Immunopathogenesis of Rheumatoid Arthritis. Immunity. 2017;46(2):183-196.
Ingegnoli F, Castelli R, Gualtierotti R. Rheumatoid factors: clinical applications. Disease Markers. 2013;35(6):727-734.
Yu HC, Lu MC. The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis. Tzu-chi medical journal. 2019;31(1):5-10.
Smith MD, Baeten D, Ulfgren AK, et al. Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go? Annals of Rheumatic Diseases. 2006;65(1):93-100.
Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis & Rheumatology. 1981;24(12):1550-1560.
Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Research & Therapy. 2002;4 Suppl 3(Suppl 3):S81-90.
Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356-361.
Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. The New England Journal of Medicine. 2001;344(12):907-916.
Maeda K, Yoshida K, Nishizawa T, et al. Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. International Journal of Molecular Sciences. 2022 Mar 6;23(5):2871..
Smeets TJ, Dolhain RJ, Breedveld FC, et al. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. The Journal of Pathology. 1998;186(1):75-81.
Goldenberg DL, Cohen AS. Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore). 1978;57(3):239-252.
Tak PP, Thurkow EW, Daha MR, et al. Expression of adhesion molecules in early rheumatoid synovial tissue. Clinical Immunology and Immunopathology. 1995;77(3):236-242.
Baeten D, Demetter P, Cuvelier C, et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Annals of Rheumatic Diseases. 2000;59(12):945-953.
Veale DJ, Orr C, Fearon U. Cellular and molecular perspectives in rheumatoid arthritis. Seminars in Immunopathology. 2017;39(4):343-354.
Fleming A, Crown JM, Corbett M. Early rheumatoid disease. I. Onset. Annals of Rheumatic Diseases. 1976;35(4):357-360.
Healy A, Farmer S, Pandyan A, et al. A systematic review of randomised controlled trials assessing effectiveness of prosthetic and orthotic interventions. PLoS One. 2018;13(3):e0192094.
Figus FA, Piga M, Azzolin I, et al. Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmunity Reviews. 2021;20(4):102776.
Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis & Rheumatology. 2005;52(3):722-32.
Alunno A, Gerli R, Giacomelli R, et al. Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis. BioMed Research International. 2017;2017:7915340.
Kröner PT, Tolaymat OA, Bowman AW, et al. Gastrointestinal Manifestations of Rheumatological Diseases. The American Journal of Gastroenterology. 2019;114(9):1441-1454.
Ramos-Remus C, Duran-Barragan S, Castillo-Ortiz JD. Beyond the joints: neurological involvement in rheumatoid arthritis. Clinical Rheumatology. 2012;31(1):1-12.
Lynch MA, Mills KH. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases. Brain, Behavior, and Immunity. 2012;26(1):1-10.
Verhoeven F, Tordi N, Prati C, et al. Physical activity in patients with rheumatoid arthritis. Joint Bone Spine. 2016;83(3):265-270.
Pu D, Luo J, Wang Y, et al. Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level. Clinical Rheumatology. 2018;37(1):179-184.
Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Medicine. 2013;11:95.
Kemp E, Nielsen H, Petersen LJ, et al. Newer immunomodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis. Clinical Nephrology. 2001;55(1):87-88.
Simon TA, Thompson A, Gandhi KK, et al. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Research & Therapy. 2015;17(1):212.
Cojocaru M, Cojocaru IM, Silosi I, et al. Extra-articular Manifestations in Rheumatoid Arthritis. Mædica - a Journal of Clinical Medicine. 2010;5(4):286-291.
Grassi W, De Angelis R, Lamanna G, et al. The clinical features of rheumatoid arthritis. European Journal of Radiology. 1998;27 Suppl 1:S18-24.
Wen J, Liu J, Xin L, et al. Effective factors on Sharp Score in patients with rheumatoid arthritis: a retrospective study. BMC Musculoskeletal Disorders. 2021;22(1):865.
Pisetsky DS, St Clair EW. Progress in the treatment of rheumatoid arthritis. The Journal of the American Medical Association. 2001;286(22):2787-2790.
Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338-2348.
Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Annals of Rheumatic Diseases. 2011;70(3):404-413.
Doan T, Massarotti E. Rheumatoid arthritis: an overview of new and emerging therapies. The Journal of Clinical Pharmacology. 2005;45(7):751-762.
Mota LM, Cruz BA, Brenol CV, et al. Guidelines for the drug treatment of rheumatoid arthritis. Revista Brasileira de Reumatologia. 2013;53(2):158-183.
Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of Rheumatic Diseases. 2020;79(6):685-699.
Burmester GR, Feist E, Dörner T. Emerging cell and cytokine targets in rheumatoid arthritis. Nature Reviews Rheumatology. 2014;10(2):77-88.
O'Shea JJ, Kontzias A, Yamaoka K, et al. Janus kinase inhibitors in autoimmune diseases. Annals of Rheumatic Diseases. 2013;72 Suppl 2(0 2):ii111-5.
Blanco-Morales EA, Bravo-Ferrer Acosta JM, Rubio Romero E, et al. Glucocorticoids in rheumatoid arthritis: almost always or hardly ever?. Reumatologia Clinica. 2011;7(6):407-411.
Townsend HB, Saag KG. Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks. Clinical and Experimental Rheumatology. 2004;22(5 Suppl 35):S77-82.
Wang Y, Zhao R, Gu Z, et al. Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis. Osteoporosis International. 2020;31(8):1401-1409.
